![Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/270faa81-adb1-4e47-8633-1133570edf62/fx1_lrg.jpg)
Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids
![ncRNA | Free Full-Text | The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer ncRNA | Free Full-Text | The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer](https://pub.mdpi-res.com/ncrna/ncrna-08-00081/article_deploy/html/images/ncrna-08-00081-ag.png?1675596739)
ncRNA | Free Full-Text | The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer
![Cancers | Free Full-Text | HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells Cancers | Free Full-Text | HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells](https://www.mdpi.com/cancers/cancers-14-02164/article_deploy/html/images/cancers-14-02164-g001.png)
Cancers | Free Full-Text | HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells
![Frontiers | How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response? Frontiers | How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?](https://www.frontiersin.org/files/Articles/332579/fmicb-08-02684-HTML/image_m/fmicb-08-02684-g001.jpg)